13F-HR filed by Ghost Tree Capital, LLC
Ghost Tree Capital, LLC filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-05-15, with 72 holding rows worth $361,294,423.
- Accession
- 0001420506-24-000902
- Filer
- CIK 1595851
- Filed
- 2024-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2024
A holdings report, 72 entries on the cover page, a total value of $361,294,423 stated on the cover page (in dollars after the unit check, H1), rows summing to $361,294,423 with VALUE read as dollars as filed, 13F file number 028-16059. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPDR SER TR | 78464A870 | S&P BIOTECH | 250,000 | $23,722,500 | dollars as filed | put |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 210,000 | $16,758,000 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 125,000 | $16,182,500 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 285,000 | $15,586,650 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 300,000 | $15,069,000 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 1,300,000 | $13,702,000 | dollars as filed | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 825,000 | $12,548,250 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 625,000 | $10,943,750 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 300,000 | $10,905,000 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 200,000 | $9,362,000 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 60,000 | $8,967,000 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 200,000 | $8,560,000 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 1,600,000 | $7,968,000 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 130,000 | $7,641,400 | dollars as filed | |
| PERSPECTIVE THERAPEUTICS INC | 46489V104 | COM | 6,000,000 | $7,140,000 | dollars as filed | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 72,761 | $6,902,108 | dollars as filed | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 225,000 | $6,653,250 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 80,000 | $6,560,000 | dollars as filed | call |
| VAXCYTE INC COM | 92243G108 | Stock | 95,000 | $6,489,450 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 375,000 | $6,397,500 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 73,002 | $5,986,164 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 125,000 | $5,416,250 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 175,000 | $5,411,000 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 650,000 | $5,310,500 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 75,000 | $5,258,250 | dollars as filed | call |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 485,000 | $5,150,700 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 150,000 | $4,846,500 | dollars as filed | call |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 225,000 | $4,160,250 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 150,000 | $4,069,500 | dollars as filed | |
| TENAYA THERAPEUTICS INC | 87990A106 | COM | 775,000 | $4,053,250 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 125,000 | $4,038,750 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 100,000 | $3,793,000 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 200,000 | $3,698,000 | dollars as filed | call |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 150,000 | $3,570,000 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 50,000 | $3,460,000 | dollars as filed | call |
| ENGENE HOLDINGS INC | 29286M105 | COM | 200,000 | $3,390,000 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 75,000 | $3,292,500 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 75,000 | $3,214,500 | dollars as filed | |
| HELIX ACQUISITION CORP II | G4444H101 | CL A ORD SHS | 300,000 | $3,120,000 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 450,000 | $3,024,000 | dollars as filed | |
| AQUESTIVE THERAPEUTICS INC COM | 03843E104 | Stock | 702,941 | $2,994,529 | dollars as filed | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 176,513 | $2,776,549 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 950,000 | $2,726,500 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 300,000 | $2,694,000 | dollars as filed | call |
| GERON CORP | 374163103 | COM | 800,000 | $2,640,000 | dollars as filed | |
| MARINUS PHARMACEUTICALS INC | 56854Q200 | COM NEW | 285,000 | $2,576,400 | dollars as filed | |
| ALTIMMUNE INC | 02155H200 | COM NEW | 250,000 | $2,545,000 | dollars as filed | |
| REGENXBIO INC | 75901B107 | COM | 120,000 | $2,528,400 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 14,000 | $2,491,020 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 200,000 | $2,372,000 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 25,000 | $2,286,500 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 200,000 | $2,264,000 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 56,941 | $2,234,365 | dollars as filed | |
| REVANCE THERAPEUTICS INC | 761330109 | COM | 450,000 | $2,214,000 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 75,000 | $2,169,750 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 90,000 | $1,860,300 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 6,500 | $1,735,760 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 40,000 | $1,651,200 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 115,000 | $1,618,625 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 210,603 | $1,598,477 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 20,000 | $1,402,200 | dollars as filed | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 600,000 | $1,308,000 | dollars as filed | |
| ELEVATION ONCOLOGY INC COM | 28623U101 | Stock | 250,000 | $1,282,500 | dollars as filed | |
| NEUROGENE INC | 64135M105 | COMMON STOCK | 25,000 | $1,272,500 | dollars as filed | |
| SAGIMET BIOSCIENCES INC A | 786700104 | COMMON STOCK | 225,000 | $1,219,500 | dollars as filed | |
| ATYR PHARMA INC | 002120202 | COM NEW | 600,000 | $1,170,000 | dollars as filed | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 675,000 | $1,147,500 | dollars as filed | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 35,000 | $1,001,000 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 20,000 | $933,800 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 165,000 | $858,000 | dollars as filed | |
| AN2 THERAPEUTICS INC | 037326105 | COM | 219,331 | $712,826 | dollars as filed | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 25,000 | $687,750 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-24-000902 | this filing | 2024-05-15 | acceptance time not in the bulk data set |